Subject: Vestex Research Announcement
From: "Ben Favret" <[email-masked]>
To: <[email-masked]>
Date: Mon, 12 Jul 2010 12:07:13 -0400

Vestagen Announces Completion of First Clinical Trial of Vestex™
Virginia Commonwealth University Researchers Encouraged by Results

Vestagen Technical Textiles today announced the completion of the first clinical
trial involving its Vestex™ nanotechnology-based products. The clinical trial
was conducted by the Department of Epidemiology and
Infection Control at Virginia Commonwealth University (VCU).

Medical research has consistently documented that garments and fabrics used in
the healthcare environment including scrubs, uniforms, lab coats, privacy
curtains and gowns are contaminated with high levels of dangerous microbes such
as MRSA, which may pose a threat to health care workers, their patients and the
community.

The 16-week, blinded cross-over clinical trial compared levels of bacterial
contamination, known as Colony Forming Unit (CFU) counts, on Vestex treated
scrubs versus standard scrubs. More than 300 cultures were performed on 32
health care workers in a medical respiratory intensive care unit.

The landmark study was led by Gonzalo Bearman, MD, MPH, associate professor of
medicine, epidemiology and community medicine at VCU. “The results for this
study are encouraging,” said Bearman, “as the Vestex scrubs had significantly
fewer MRSA colonies.”

“We are very pleased with the outcome of The Virginia Commonwealth University
research of our technology,” said Ben Favret, president and CEO of Vestagen.
“This data further supports the evidence-based research documenting the
clinical, operational and financial benefits of Vestex.”

The performance of Vestex is the result of impregnated nano-sized particles
that change the surface area of the fabric, increasing surface tension. The
proprietary technology creates a barrier to contaminants and fluids such as
blood. The repellency of the barrier protection sheds bulk contaminants
allowing the imbedded
antimicrobial properties of Vestex to control microorganisms on the fabric.

"We hope that this technology, when coupled with hand hygiene and other
infection control measures, will aid in the prevention of hospital acquired
infections and protect healthcare workers," said Bearman

Vestex products, including scrubs, lab coats, protective isolation gowns and
longsleeved T-shirts, are currently available for sale. orders can be placed
online at www.vestexprotects.com. For information on placing an institutional
order, please contact Lorrie Anderson, director of marketing, at 407-781-2570.

About Vestagen Technical Textiles LLC Vestagen Technical Textiles is an
Orlando-based marketer and manufacturer of advanced performance textiles.
Vestagen is led by a skilled management team with nearly a century of combined
experience in the health care textile and apparel industries. Backed by V-Ten
Capital Partners, Vestagen is committed to creating innovative textile
solutions. For more information, visit [1]www.vestagen.com and
[2]www.vestexprotects.com

References

1. http://www.vestagen.com/
2. http://www.vestexprotects.com/
This message was sent by: Vestagen Technical Textiles, LLC, 1301 W. Colonial Dr, Orlando, FL 32804

Manage your subscription:
http://app.icontact.com/icp/mmail-mprofile.pl?r=48406493&l=78796&s=O5L4&m=623311&c=303934

Forward to a friend: 
http://app.icontact.com/icp/core/message/forward?m=623311&s=48406493&c=O5L4&cid=303934